These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2863915)

  • 21. Growth hormone and somatomedin-C response to synthetic human pancreatic tumor GH-releasing factor in hypopituitary and constitutionally short children.
    Minuto F; Barreca A; Del Monte P; Mauri R; Resentini M; Fortini P; Morabito M; Giordano G
    J Endocrinol Invest; 1986 Dec; 9(6):447-52. PubMed ID: 3106458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.
    Webb CB; Vance ML; Thorner MO; Perisutti G; Thominet J; Rivier J; Vale W; Frohman LA
    J Clin Invest; 1984 Jul; 74(1):96-103. PubMed ID: 6429198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH.
    Vance ML; Kaiser DL; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1986 Mar; 62(3):591-4. PubMed ID: 3080467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma somatotropin response to exogenous growth hormone releasing factor in lambs.
    Kensinger RS; McMunn LM; Stover RK; Schricker BR; Maccecchini ML; Harpster HW; Kavanaugh JF
    J Anim Sci; 1987 Apr; 64(4):1002-9. PubMed ID: 3106295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing with growth hormone-releasing factor (GRF(1-29)NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency.
    Ranke MB; Gruhler M; Rosskamp R; Brügmann G; Attanasio A; Blum WF; Bierich JR
    Eur J Pediatr; 1986 Dec; 145(6):485-92. PubMed ID: 2880720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary growth hormone response in rats during a 24-hour infusion of growth hormone-releasing factor.
    Wehrenberg WB; Brazeau P; Ling N; Textor G; Guillemin R
    Endocrinology; 1984 May; 114(5):1613-6. PubMed ID: 6143658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma growth hormone (GH) responses to single and repetitive subcutaneous administration of GH releasing factor (hpGRF-44) in normal and GH deficient children.
    Takano K; Hizuka N; Shizume K; Honda N; Ling NC
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):11-9. PubMed ID: 3918397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restoration of juvenile baseline growth hormone secretion with preservation of the ultradian growth hormone rhythm by continuous delivery of growth hormone-releasing factor.
    Vasilatos-Younken R; Tsao PH; Foster DN; Smiley DL; Bryant H; Heiman ML
    J Endocrinol; 1992 Nov; 135(2):371-82. PubMed ID: 1474343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Coude FX; Arnone M; Morre M; Uboldi F; Barbeau C
    J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human growth hormone-releasing hormone (hGH-RH; hGRF) treatment of four patients with GH deficiency.
    Takano K; Hizuka N; Asakawa K; Chihara K; Sanayama K; Shizume K
    Endocrinol Jpn; 1988 Oct; 35(5):775-81. PubMed ID: 3146502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men.
    Hulse JA; Rosenthal SM; Cuttler L; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1986 Oct; 63(4):872-8. PubMed ID: 3091629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men.
    Jaffe CA; Ho PJ; Demott-Friberg R; Bowers CY; Barkan AL
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone (GH) secretion during continuous infusion of GH-releasing peptide: partial response attenuation.
    DeBell WK; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1312-6. PubMed ID: 2026752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-somatostatin rebound secretion of growth hormone is dependent on growth hormone-releasing factor in unrestrained female rats.
    Sugihara H; Minami S; Wakabayashi I
    J Endocrinol; 1989 Aug; 122(2):583-91. PubMed ID: 2570118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exogenous growth hormone inhibits growth hormone-releasing factor-induced growth hormone secretion in normal men.
    Rosenthal SM; Hulse JA; Kaplan SL; Grumbach MM
    J Clin Invest; 1986 Jan; 77(1):176-80. PubMed ID: 3080472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of growth hormone (GH) secretion by GH-releasing factor, somatostatin, and insulin-like growth factor I in ovine fetal and neonatal pituitary cells in vitro.
    Silverman BL; Bettendorf M; Kaplan SL; Grumbach MM; Miller WL
    Endocrinology; 1989 Jan; 124(1):84-9. PubMed ID: 2562828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha 2-adrenergic control of growth hormone (GH) secretion in conscious male rabbits: involvement of endogenous GH-releasing factor and somatostatin.
    Minamitani N; Chihara K; Kaji H; Kodama H; Kita T; Fujita T
    Endocrinology; 1989 Dec; 125(6):2839-45. PubMed ID: 2479528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between growth hormone releasing factor (GRF) and somatostatin analogue (SMS 201-995) in normal subjects.
    Losa M; Müller OA; Sobieszczyk S; von Werder K
    Clin Endocrinol (Oxf); 1985 Dec; 23(6):715-20. PubMed ID: 2869845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.